SEATTLE & INNSBRUCK, Austria--(BUSINESS WIRE)--Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback